2,4-Di([1,1'-biphenyl]-3-yl)-6-chloro-1,3,5-triazine

Catalog No. :
ACPFWL712
CAS No. :
1205748-61-3
Molecular Formula :
C27H18ClN3
Molecular Weight :
419.92

IUPAC Name:2,4-di([1,1'-biphenyl]-3-yl)-6-chloro-1,3,5-triazine

2,4-Di([1,1'-biphenyl]-3-yl)-6-chloro-1,3,5-triazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$69.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,4-Di([1,1'-biphenyl]-3-yl)-6-chloro-1,3,5-triazine
IUPAC Name2,4-di([1,1'-biphenyl]-3-yl)-6-chloro-1,3,5-triazine
MDL No.-
Molecular FormulaC27H18ClN3
Molecular Weight419.92
SMILESClC1=NC(C2=CC(C3=CC=CC=C3)=CC=C2)=NC(C4=CC(C5=CC=CC=C5)=CC=C4)=N1
InChI KeySVNMSEVGOAHNKQ-UHFFFAOYSA-N
Synonym2-chloro-4,6-di(biphenyl-3-yl)-1,3,5-triazine;2,4-Di([1,1'-biphenyl]-3-yl)-6-chloro-1,3,5-triazine;2,4-di(biphenyl-3-yl)-6-chloro-1,3,5-triazine;2,4-bis([1,1-biphenyl]-3-yl)-6-chloro-1,3,5-Triazine;1,3,5-triazine, 2,4-bis([1,1'-biphenyl]-3-yl)-6-chloro-;2-Chloro-4,6-bis(3-biphenyl)1,3,5-triazine
CAS No.1205748-61-3
PubChem CID58299118

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACPFWL712 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6 In Stock
  4. Then
  5. ACPFWL712 route product structure diagram
    ACPFWL7121205748-61-3
Inquiry

2. ACPFWL712 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6 In Stock
  4. Then
  5. ACPFWL712 route product structure diagram
    ACPFWL7121205748-61-3
Inquiry

Comments (0)